Results of directly applied activated carbon cloth in chronic wounds: a preliminary study
| Autor: | M Kaiser, H S Scheer, U Zingg |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Nursing (miscellaneous) Wound therapy Adolescent Cost-Benefit Analysis medicine.medical_treatment Comorbidity Young Adult 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Diabetes Mellitus medicine Humans Mass index Aged Retrospective Studies Angiology Wound clinic Aged 80 and over Wound Healing integumentary system business.industry Malnutrition Arterial perfusion Skin Transplantation Middle Aged Bandages Carbon Surgery 030220 oncology & carcinogenesis Chronic Disease Wounds and Injuries Skin grafting Female Fundamentals and skills Median body Wound healing business Negative-Pressure Wound Therapy Switzerland Bandages Hydrocolloid |
| Zdroj: | Journal of Wound Care. 26:476-481 |
| ISSN: | 2052-2916 0969-0700 |
| DOI: | 10.12968/jowc.2017.26.8.476 |
| Popis: | Objective: Activated carbon (AC) has been used in wound therapy as an active substance inside dressings. Applying AC directly on a wound is a new concept. The aim of this study was to analyse the outcomes of chronic wounds which were managed with directly applied activated carbon knitted cloth (ACC, Zorflex) in Swiss patients. Method: A retrospective analysis of the records of all patients with chronic wounds treated with ACC between 1 October 2013 and 31 December 2015 in an outpatient wound clinic. Chronic was defined as a wound being present for >3 weeks. Malignant wounds were excluded. The main outcome was the time to complete closure or readiness for spilt-thickness skin grafting (STSG). Descriptive data, including nutritional status and angiology results were obtained. Results: There were 36 women and 34 men, median age 68 years old. The median body mass index (BMI) 28.1kg/m2 and 76% (n=53) of patients had comorbidities. Angiology exam results showed signs of reduced arterial perfusion in 13% (n=9) of patients and malnutrition in 11% (n=8). Of the wounds included 34% (n=24) were on the trunk and 66% (n=46) on the extremities. The median wound size was 6.9cm2 (range: 0.1-300cm2). The wounds on the trunk were larger than wounds on extremities (10 versus 2cm2). Overall, median time to wound closure was 51 days. In 94% (n=66) of patients, wounds closed without further intervention and 6% (n=4) underwent STSG. Patients with comorbidities showed longer wound healing times compared with those without. No adverse events such as allergies or skin irritation occurred. Cost analysis, including personnel and material and stratified according known wound closure times, showed ACC (US$ 1252) to be like hydrocolloids (US$ 1128), but substantially lower than white gauze (US$ 3026) and negative pressure wound therapy (NPWT) (US$ 2578). Conclusion: ACC applied directly on chronic wounds of different aetiology is safe with short closure times. The cost efficiency is high. It combines the positive features of other wound dressings, such as hydrocolloids and NPWT, without their disadvantages. The dressing change of ACC is easy and non-specialised nurses or even patients themselves can be taught to perform it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|